Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001649094-25-000074
Filing Date
2025-05-07
Accepted
2025-05-07 16:23:38
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pcvx-20250331.htm   iXBRL 10-Q 1409558
2 EX-10.1 pcvx-20250331exhibit101.htm EX-10.1 61864
3 EX-10.2 pcvx-20250331exhibit102.htm EX-10.2 43631
4 EX-31.1 pcvx-20250331exhibit311.htm EX-31.1 11484
5 EX-31.2 pcvx-20250331exhibit312.htm EX-31.2 11630
6 EX-32.1 pcvx-20250331exhibit321.htm EX-32.1 7136
  Complete submission text file 0001649094-25-000074.txt   6664876

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20250331.xsd EX-101.SCH 50296
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcvx-20250331_cal.xml EX-101.CAL 66561
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcvx-20250331_def.xml EX-101.DEF 220669
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20250331_lab.xml EX-101.LAB 638220
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20250331_pre.xml EX-101.PRE 418088
73 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20250331_htm.xml XML 722438
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39323 | Film No.: 25921803
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)